[2].
Bartolini M.,
Andrisano V. 2010, Strategies for the inhibition of protein aggregation in human diseases. ChemBioChem. 11(8): 1018–1035.
[3].
Booth A.N.,
Deeds F. 1958, The toxicity and metabolism of dihydroquercetin. Journal of American Pharmaceutical Association. Americal Pharmaceutical Association. 47(3, part1):183–184.
[5]. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C.M., Stefani, M. 2002, Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature, 416(6880): 507–511.6.
[6]. Chiti F., Dobson C.M. 2006, Protein misfolding, functional amyloid and human disease. Annual Review of Biochemistry.75:333–366.
[7].
De Felice F.G.,
Ferreira S.T. 2002, β-Amyloid production, aggregation, and clearance as targets for therapy in Alzheimer’s disease. Cellular and Molecular Neurobiology. 22(5-6):545–5638.
[10].Goldberg M.E., Rudolph R., Jaenicke R. 1991, A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme. Biochemistry. 30(11): 2790–2797.
[11].Klunk W.E., Pettegrew J.W., Abraham D.J. 1989, Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. The Journal of Histochemistry and Cytochemistry. 37(8): 1273–1281.
[14].Mishra, R., Sellin, D., Radovan, D., Gohlke, A., Winter, R. 2009, Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol. ChemBioChem. 10(3): 445–449.
[16].Meratan A.A., Ghasemi A., Nemat-Gorgani M. 2011, Membrane integrity and amyloid cytotoxicity: a model study involving mitochondria and lysozyme fibrillation products. Journal of Molecular Biology. 409(5): 826–838.
[17].Pepys M.B., Hawking P.N., Booth D.R., Vigushin D.M., Tennent G.A., Soutar A.K., Totty N., Nguyen O., Blake C.C., Terry C.J., Feest T.G., Zalin A.M., Hsuan J.J. 1993, Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature. 362(6420): 553–557.
[18].
Porat Y.,
Abramowitz A.,
Gazit E. 2006, Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chemical Biology & Drug Design. 67(1):27–37.
[19].
Saito S.,
Yamamoto Y.,
Maki T.,
Hattori Y.,
Ito H.,
Mizuno K.,
Harada-Shiba M.,
Kalaria R.N.,
Fukushima M.,
Takahashi R.,
Ihara M.2017, Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy. Acta Neuropathologica Communications. 5(1):26.
[20].
Sato M.,
Murakami K.,
Uno M.,
Ikubo H.,
Nakagawa Y.,
Katayama S.,
Akagi K.,
Irie K.2013, Structure–Activity relationship for ()-taxifolin isolated from Silymarin as an inhibitor of Amyloid β Aggregation. Bioscience, Biotechnology, and Biochemistry. 77(5):1100–1103.
[23].Siebert K.J., Troukhanova N.V., Lynn, P.Y. 1996, Nature of polyphenol-protein interactions. Journal of Agricaltural and Food Chemistry. 44(1):80–85.
[24].
Soares S.,
Mateus N.,
Freitas Vd. 2007, Interaction of different polyphenols with bovine serum albumin (BSA) and human salivary alpha-amylase (HSA) by fluorescence quenching. Journal of Agricaltural and Food Chemistry. 2007; 55(16):6726–6735.
[25].Soto C. 1999, Plaque busters: strategies to inhibit amyloid formation in Alzheimer’s disease. Molecular Medicine Today. 5(8):343–350.
[26].
Stefani M.,
Rigacci S. 2013, Protein folding and aggregation into amyloid: the interference by natural phenolic compounds. International Journal of Molecular Sciences. 14(6):12411–12457.
[30].Wang S.S.S., Chen P.H., Hung Y.T. 2006, Effects of p-benzoquinone and melatonin on amyloid fibrillogenesis of hen egg-white lysozyme. Journal of Molecular Catalysis B-Enzymatic. 43(1-4):49–57.
[31].
Wang J.B.,
Wang Y.M.,
Zeng C.M. 2011, Quercetin inhibits amyloid fibrillation of bovine insulin and destabilizes preformed fibrils. Biochemical and Biophysical Research Communications. 415(4):675–679.
[32].Weidmann A.E. 2012, Dihydroquercetin: More than just an impurity? European Journal of Pharmacology. 684(1-3):19–26.